← Syndax Pharmaceuticals Inc SNDX
Market Price
$19.85
Market Cap
$1.69B
P/E Ratio
N/A
Revenue (FY 2025)
↑627.8% YoY
$172.35M
Full year reported
Net Income
↑10.5% YoY
-$285.42M
Net Margin: -165.6%
Free Cash Flow
↓-17.6% YoY
-$323.17M
FCF Yield: -19.12%
EPS (Diluted)
↑11.6% YoY
$-3.29
Basic: $-3.29
Return on Equity
Efficiency
-441.6%
ROA: -2,114.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SNDX)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2019: Revenue YoY (+0.0%) is identical to Gross Profit YoY (+0.0%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
- FY 2020: Revenue YoY (+0.0%) is identical to Gross Profit YoY (+0.0%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1.2M | — | $0.3M | $-44.5M | — | $-3.22 | — | $-35.2M | $-35.4M | — |
| FY 2017 | $2.1M | +72.8% | $0.7M | $-60.8M | -36.7% | $-2.90 | +9.9% | $-47.4M | $-47.5M | -34.0% |
| FY 2018 | $1.5M | -28.0% | $1.5M | $-74.0M | -21.6% | $-2.92 | -0.7% | $-68.5M | $-68.7M | -44.8% |
| FY 2019 | $1.5M | 0.0% | $1.5M | $-56.0M | +24.2% | $-1.84 | +37.0% | $-50.6M | $-50.8M | +26.1% |
| FY 2020 | $1.5M | 0.0% | $1.5M | $-73.2M | -30.5% | $-1.87 | -1.6% | $-71.3M | $-71.3M | -40.3% |
| FY 2021 | $139.7M | +9,109.6% | $137.8M | $24.9M | +134.1% | $0.46 | +124.6% | $29.1M | $29.0M | +140.7% |
| FY 2022 | — | -100.0% | — | $-149.3M | -699.1% | $-2.46 | -634.8% | $-133.7M | $-133.7M | -560.9% |
| FY 2023 | — | — | — | $-209.4M | -40.2% | $-2.98 | -21.1% | $-160.6M | $-160.6M | -20.1% |
| FY 2024 | $23.7M | — | $18.8M | $-318.8M | -52.3% | $-3.72 | -24.8% | $-274.9M | $-274.9M | -71.2% |
| FY 2025 | $172.4M | +627.8% | $172.3M | $-285.4M | +10.5% | $-3.29 | +11.6% | $-323.0M | $-323.2M | -17.6% |
Valuation
Market Price
$19.85
Market Cap
$1.69B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
27.22
FCF Yield
-19.12%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
100.00%
Operating Margin
-158.45%
Net Margin
-165.60%
Return on Equity (ROE)
-441.62%
Return on Assets (ROA)
-2,114.86%
Asset Turnover
12.77x
Revenue 3-Yr CAGR
N/A
Financial Health & Liquidity
Current Ratio
0.11
Cash Ratio
1.12
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$134.93M
Total Debt
N/A
Book Value / Share
$0.73
Cash Flow Efficiency
Operating Cash Flow
-$322.98M
Capital Expenditures (CapEx)
$187.00K
Free Cash Flow
-$323.17M
OCF / Revenue
-187.40%
FCF / Revenue
-187.50%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-3.29
EPS (Basic)
$-3.29
Dividends / Share
N/A
Book Value / Share
$0.73
EPS YoY Growth
11.56%
Balance Sheet (FY 2025)
Total Assets
$13.50M
Total Liabilities
$120.12M
Stockholders' Equity
$64.63M
Current Assets
$13.50M
Current Liabilities
$120.12M